ATM and prostate cancer: Case 4 presents a 74-year-old male with extensive metastatic disease who initially responded to the treatment but later exhibited disease advancement and an <i>ATM</i> gene mutation, signaling a shift to metastatic castration-resistant prostate cancer (mCRPC).